share_log

Hill Street Reports FY 2022 Q2 & Year-to-Date Results, Expansion of DehydraTECH(TM) Licensing Business into New States, and Ticker Change to Reflect Hill Street's Growth and Evolution

Hill Street Reports FY 2022 Q2 & Year-to-Date Results, Expansion of DehydraTECH(TM) Licensing Business into New States, and Ticker Change to Reflect Hill Street's Growth and Evolution

Hill Street报告2022财年第二季度和今年迄今的业绩、DehyTECH(TM)许可业务向新州的扩展,以及反映Hill Street公司增长和演变的Ticker变化
newsfile ·  2022/03/01 08:40

Highlights:

重点:

  • Increased gross profit for the six months ended December 31, 2021 by 12% Year over Year with a 9% increase in net revenue Year over Year
  • Grew gross profit margin for the six months ended December 31, 2021 from 42% to 48% Year over Year, reflecting the improved financial impact of the DehydraTECH™ licensing business
  • Expanded rights in Illinois and Massachusetts to existing partner Dehydr8, LLC for licensing of DehydraTECH™ fast-acting cannabinoid delivery system technology to IL and MA contract manufacturers and licensed producers for B2B and B2C THC applications
  • Intends to obtain approval of the TSX Venture Exchange to change the Company's ticker symbol from "BEER" to "HILL", to reflect the Company's growth and evolution
  • 截至2021年12月31日的6个月毛利润同比增长12%,净收入同比增长9%
  • 截至2021年12月31日的6个月,毛利率同比增长42%至48%,反映出DehyTECH™许可业务的财务影响有所改善
  • 扩大了在伊利诺伊州和马萨诸塞州的现有合作伙伴Deah8,LLC的权利,向IL和MA合同制造商以及B2B和B2C THC应用的特许生产商许可DehyTECH™快速作用大麻递送系统技术
  • 拟获得多伦多证券交易所创业板批准,将公司股票代码由“BEAR”改为“HILL”,以反映公司的成长和发展

Toronto, Ontario--(Newsfile Corp. - March 1, 2022) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company") reported its fiscal year 2022 second quarter results for the three-month and six-month periods ended December 31, 2021. A complete set of financial statements and Management's Discussion & Analysis has been filed at . All dollar figures are quoted in Canadian dollars unless otherwise stated.

安大略省多伦多-(Newsfile Corp.-2022年3月1日)-Hill Street Beverage Company Inc.(多伦多证券交易所股票代码:BEAR)(“山街“或”公司“)报告了截至2021年12月31日的三个月和六个月期间的2022财年第二季度业绩。完整的财务报表和管理层的讨论和分析已提交到。除非另有说明,所有美元数字均以加元报价。

HIGHLIGHTS OF SECOND QUARTER BUSINESS OPERATIONS

第二季度业务运营亮点

Hill Avenue Cannabis Technologies continued its expansion into new geographic markets and with new product formats

Hill Avenue Cannabis Technologies继续向新的地理市场和新的产品模式扩张

The Company expanded the reach of a number of its DehydraTECH™ licensees as the licensees introduced their popular DehydraTECH™-powered products into new states and launched new products in the quarter. In FY2022 Q2, Nuka Enterprises LLC (1906)'s best-selling signature line of fast-acting swallowable THC pills (known as Drops) hit shelves in Arizona, and Cannadips launched a THC version of their popular original CBD pouches in California.

该公司扩大了一些DehyTECH™被许可人的覆盖面,因为这些被许可人在本季度向新的州推出了他们广受欢迎的DehyTECH™驱动的产品,并推出了新产品。在2022财年第二季度,Nuka Enterprise LLC(1906年)最畅销的THC速效吞咽药丸(称为Drops)系列在亚利桑那州上架,而Cannadips在加利福尼亚州推出了其广受欢迎的原始CBD药袋的THC版本。

Added Distribution of Hill Avenue Cannabis Brands' (V)ia Regal beyond Ontario into new provinces British Columbia and Northwest Territories

增加了Hill Avenue Cannabis Brands‘s(V)ia Regal在安大略省以外的新省份不列颠哥伦比亚省和西北地区的分销

In FY2022 Q2, Hill Street's co-packing partner Molecule Inc. secured orders from the provincial cannabis boards of British Columbia and the Northwest Territories for the original (V)ia Regal Pink Grape Sparkler and the newly-launched (V)ia Regal White Grape Sparkler, both premium cannabis-infused sparklers made from grapes imported from European vineyards.

在2022财年第二季度,Hill Street的联合包装合作伙伴Molecal Inc.从不列颠哥伦比亚省和西北地区的省级大麻委员会获得了原始(V)ia Regal粉色葡萄Sparkler和新推出的(V)ia Regal白葡萄Sparkler的订单,这两款优质注入大麻的汽水都是用从欧洲葡萄园进口的葡萄制成的。

Submitted application for a New Health Canada Cannabis Research License and continued progress on securing a Cannabis Processing License for the Ontario Lucknow Facility

提交了新的加拿大卫生部大麻研究许可证申请,并在为安大略省勒克瑙设施获得大麻加工许可证方面继续取得进展

The Company submitted an application for a Health Canada research license for its Lucknow cannabis facility in Mississauga, Ontario and also continued preparations for obtaining the Health Canada Standard Processor License for the facility, which will enable the Company to produce DehydraTECH™ fast-acting cannabinoid powder for potential B2B and B2C sales in Canada. The Company has begun construction at the facility, but delays related to municipal permits for the build-out are impacting the timing for submission of that Standard Processor License application to Health Canada.

该公司为其位于安大略省密西索加的勒克瑙大麻设施提交了加拿大卫生部研究许可证的申请,并继续为获得该设施的加拿大卫生部标准加工商许可证做准备,这将使该公司能够为加拿大潜在的B2B和B2C销售生产脱氢TECH™速效大麻素粉。该公司已经开始在该设施建设,但与扩建市政许可有关的延误正在影响向加拿大卫生部提交标准处理器许可证申请的时间。

Permanent CEO named subsequent to the quarter

本季度后任命的永久首席执行官

Subsequent to the end of Q2, on January 6, 2022, the Company announced the appointment of Craig Binkley as CEO. Binkley had been operating in the interim Co-CEO role along with fellow board member Lori Senecal since February 9, 2021. Lori Senecal has transitioned out of the interim Co-CEO role and will continue in her Board of Director role.

在第二季度结束后,即2022年1月6日,该公司宣布任命克雷格·宾克利(Craig Binkley)为首席执行官。自2021年2月9日以来,宾克利一直与董事会成员洛里·塞内卡尔(Lori Senecal)一起担任临时联席首席执行官。洛里·塞内卡尔已经辞去临时联席首席执行官一职,将继续担任董事董事会的职务。

FINANCIAL HIGHLIGHTS FOR THE SIX MONTHS ENDING DECEMBER 31, 2021

截至2021年12月31日的六个月的财务摘要

Financial results for the six months year-to-date show significant improvements that reflect the growing impact of the DehydraTECH™ business on the Company's financial fundamentals.

今年到目前为止的6个月的财务业绩显示出重大改善,这反映出DehyTECH™业务对公司财务基本面的影响越来越大。

Net revenue increased 9% for the six-month period ending December 31, 2021 compared to the same period prior year, while gross profit increased 12% and gross profit margin improved six points from 42% to 48%. After adjusting for the impact of discontinued alcohol-free beer operations and inventory valuation adjustments made in the first half of FY 2021, net revenue for the first six months of FY 2022 increased 13%, while gross profit increased a full 30% and gross profit margin improved nine points from 39% to 48% for the six-month period.

在截至2021年12月31日的六个月里,净收入同比增长9%,毛利润增长12%,毛利率从42%提高到48%,增幅为6个百分点。在对2021财年上半年停产的无酒精啤酒业务和库存估值调整的影响进行调整后,2022财年前六个月的净收入增长了13%,毛利润增长了整整30%,毛利率从39%提高到48%,增幅为9个百分点。

"The year-to-date performance continued to exhibit the transformative power of our DehydraTECH™ licensing business on the overall financial measures of Hill Street", commented Craig Binkley, CEO of Hill Street. "The consolidated revenues, gross profit and gross profit margin are all improved by the escalating impact of this critical growth driver".

希尔街首席执行官克雷格·宾克利评论说:“今年到目前为止,我们的DehyTECH™许可业务在希尔街的整体财务措施上继续显示出变革性的力量。”“合并营收、毛利率和毛利率都受到这一关键增长动力不断升级的影响的改善。”

Q2 FINANCIAL HIGHLIGHTS

第二季度财务亮点

While the six-month year-to-date financial results show strong positive trends, second quarter comparisons to year ago were negatively impacted by a quarterly shift in alcohol-free beverage revenues in the prior year.

虽然今年到目前为止的6个月的财务业绩显示出强劲的积极趋势,但与去年同期相比,第二季度受到了前一年无酒精饮料收入季度变化的负面影响。

Q2 FY21 was an extraordinary quarter for Hill Street alcohol-free beverage revenues, as sales were shifted from Q1 FY21 and elevated dramatically beyond normal by the impact of retailers and distributors restocking empty shelves and pipeline inventories that were emptied by global pandemic and supply chain issues in Q1 FY21. Comparative revenues year ago also included the alcohol-free beer business that has since been discontinued.

对于Hill Street无酒精饮料收入来说,21财年第二季度是一个非同寻常的季度,因为销售额从21财年第一季度转移到了正常水平,原因是零售商和分销商重新进货空置货架和管道库存的影响,这些库存在21财年第一季度因全球流行病和供应链问题而被清空。一年前的可比收入还包括后来停产的不含酒精啤酒业务。

As a result of the quarterly revenue shift and the discontinuation of alcohol-free beer, consolidated net revenues for Q2 FY22 declined 32% vs. Q2 prior year, moderating the six-month net revenue growth to 9%. After the quarterly shift and recovery in inventories, future net revenues are expected to reflect positive category trends in alcohol free wine and growth for the fiscal year.

由于季度收入的转变和不含酒精啤酒的停产,22财年第二季度的合并净收入比去年第二季度下降了32%,使连续6个月的净收入增长放缓至9%。在季度转移和库存回升之后,预计未来的净收入将反映出无酒精葡萄酒的积极类别趋势和本财年的增长。

The quarterly shift in revenue also resulted in gross profit declining 33%, moderating the six-month gross profit gain to 12%. The increasing importance of the DehydraTECH™ licensing business allowed the Q2 gross profit margin to remain equal to year ago at 44%, although below the 48% margin for the full six-month period ending December 31, 2021.

收入的季度变化也导致毛利润下降33%,将6个月的毛利润增长放缓至12%。DehyTECH™许可业务的重要性日益增加,使得第二季度毛利率与去年同期持平,为44%,但低于截至2021年12月31日的6个月的48%。

RESULTS OF OPERATIONS

行动结果

The following table summarizes certain financial information of the Company for the three months and six months ended December 31, 2021, and the three months and six months ended December 31, 2020.

下表汇总了本公司截至2021年12月31日的三个月和六个月以及截至2020年12月31日的三个月和六个月的某些财务信息。

Consolidated Results for the Period Ended Quarter Ended
 December 31,
2021
Quarter Ended
December 31,
 2020
Six Months Ended
December 31,
2021
Six Months Ended
December 31,
2020
Gross Revenue $576,622 $875,529 $1,237,105 $1,259,979
Chargebacks, finance fees, and listing fees -$67,885 -$129,780 -$123,629 -$239,518
Net Revenue $508,737 $745,749 $1,113,476 $1,020,461
Direct Costs -$252,280 -$363,840 -$522,597 -$492,546
Gross profit $256,457 $381,909 $590,879 $527,915
Operating Expenses (excl. One-time & non-Cash) $794,938 $757,466 $1,444,954 $1,208,186
Other One-time Expenses $0 $19,337 $16,146 $23,837
Non-Cash Expenses $187,291 $88,891 $406,592 $255,513
Loss before other Income (Expense) -$725,772 -$483,785 -$1,276,813 -$959,620
Other income (Expenses)        
Foreign exchange gain (loss) $7,872 -$3,497 $9,114 -$1,980
(Loss) gain on Settlement of liability -$2,933 $6,730 -$2,720 $6,730
Loss) gain on fair value of Consideration $20,945 $0 -$14,471 $0
Write-off of inventory -$2,522 -$0 -$20,579 -$1,535
Other Income $2,934 $30 $6,434 $30
Loss and comprehensive loss for the period -$699,476 -$480,522 -$1,299,036 -$956,375
Basic and diluted loss per common share ($0.00) ($0.00) ($0.01) ($0.01)
Weighted average number of common shares outstanding 212,294,452 122,399,917 210,647,548 117,289,721
截至该期间的综合业绩 截至的季度
十二月三十一日,
2021
截至的季度
十二月三十一日,
2020
截至六个月
十二月三十一日,
2021
截至六个月
十二月三十一日,
2020
总收入 $576,622 $875,529 $1,237,105 $1,259,979
按存储容量使用计费、财务费用和上市费 -$67,885 -$129,780 -$123,629 -$239,518
净收入 $508,737 $745,749 $1,113,476 $1,020,461
直接成本 -$252,280 -$363,840 -$522,597 -$492,546
毛利 $256,457 $381,909 $590,879 $527,915
运营费用(不包括一次性和非现金) $794,938 $757,466 $1,444,954 $1,208,186
其他一次性费用 $0 $19,337 $16,146 $23,837
非现金费用 $187,291 $88,891 $406,592 $255,513
扣除其他收入(费用)前的亏损 -$725,772 -$483,785 -$1,276,813 -$959,620
其他收入(费用)
汇兑损益 $7,872 -$3,497 $9,114 -$1,980
(损失)清偿责任的收益 -$2,933 $6,730 -$2,720 $6,730
损失)公允对价收益 $20,945 $0 -$14,471 $0
存货核销 -$2,522 -$0 -$20,579 -$1,535
其他收入 $2,934 $30 $6,434 $30
本期损失和综合损失 -$699,476 -$480,522 -$1,299,036 -$956,375
每股普通股基本和摊薄亏损 ($0.00) ($0.00) ($0.01) ($0.01)
已发行普通股加权平均数 212,294,452 122,399,917 210,647,548 117,289,721

OTHER ANNOUNCEMENTS

其他公告

Signed new DehydraTECH™ Licensing Agreements with existing Michigan partner DeHydr8, LLC ("D8") for expansion of D8's rights into Illinois and Massachusetts for potential B2B and B2C applications

与现有的密歇根州合作伙伴Dehydr8,™(“D8”)签署了新的DehyTECH许可协议,将D8的权利扩展到伊利诺伊州和马萨诸塞州,用于潜在的B2B和B2C应用

Based on the success of D8's team since acquiring DehydraTECH™ rights in Michigan in signing top-quality Michigan licensed producers to produce THC products powered by DehydraTECH™, the Company is pleased to announce that it has expanded the reach of D8's DehydraTECH™ rights to add the new states of Illinois and Massachusetts.

在获得密歇根州DehyTECH™授权后,D8的团队成功签约了密歇根州授权的顶级生产商生产由DehyTECH™驱动的THC产品,公司高兴地宣布,它已经扩大了D8的DehyTECH™授权的覆盖范围,增加了伊利诺伊州和马萨诸塞州。

Granting DehydraTECH™ rights to D8 in Illinois and Massachusetts represent further steps that the Company is taking to rapidly mobilize and monetize the patented DehydraTECH™ technology by deploying a state-by-state US rollout model to continue to accelerate the Company's financial and operational progress. Hill Street and D8 have used their joint experiences gained in Michigan to create a scalable operating model for state-by-state expansion of the DehydraTECH™ licensing business that progresses from start to monetization over an approximately 5-month period.

授予DehyTECH™公司在伊利诺伊州和马萨诸塞州D8的经营权,代表着该公司正在采取进一步措施,通过在美国各州部署推广模式,迅速动员DehyTECH™专利技术并将其货币化,以继续加快公司的财务和运营进展。Hill Street和D8利用他们在密歇根州获得的联合经验,创建了一个可扩展的运营模式,用于在大约5个月的时间内,在各州扩展DehyTECH™许可业务,从开始到货币化。

Approval Sought from TSX Venture Exchange for Ticker Change from "BEER" to "HILL"

寻求多伦多证券交易所创业板批准将Ticker从“啤酒”改为“Hill”

The Company is pleased to announce that it intends to obtain the approval of the TSX Venture Exchange to change the Company's ticker symbol from "BEER" to "HILL". The Company expects that its common shares will begin trading on the TSX Venture Exchange under the new symbol "HILL" at market open on March 3, 2022.

本公司高兴地宣布,它打算获得多伦多证券交易所创业板的批准,将本公司的股票代码由“BEAR”改为“HILL”。该公司预计其普通股将于2022年3月3日开始在多伦多证券交易所创业板交易,新代码为“HILL”。

This ticker change reflects the Company's growth and evolution beyond the domestic beverage business towards building a global, multi-business company pioneering the space where premium crafted consumer products meet bioscience.

股票代码的这一变化反映了该公司的增长和发展,超越了国内饮料业务,朝着建立一家全球多业务公司的方向发展,开创了优质精心制作的消费产品与生物科学相结合的领域。

No action is required by existing shareholders with respect to the ticker symbol change and the CUSIP/ISIN numbers assigned to the Company's common shares will not be changed.

现有股东不需要就股票代码的改变采取任何行动,分配给公司普通股的CUSIP/ISIN号码也不会改变。

Re-Filing of FY 2022 Q1 Financial Statements

重新提交2022财年第一季度财务报表

The Company also announces today that it has re-filed its unaudited condensed interim consolidated financial statements for the three-month period ended September 30, 2021 in order to incorporate a notice advising the reader that the statements have not been reviewed by an auditor. The re-filed financial statements replace and supersede the previously filed original financial statements filed on November 29, 2021 and will be available on SEDAR on March 1, 2022.

该公司今天还宣布,它已经重新提交了截至2021年9月30日的三个月的未经审计的简明中期综合财务报表,以便加入一份通知,告知读者这些报表没有经过审计师的审查。重新提交的财务报表取代和取代了之前提交的2021年11月29日提交的原始财务报表,并将于2022年3月1日在SEDAR上提供。

About Hill Street Beverage Company Inc. (TSXV: BEER)

关于希尔街饮料公司(多伦多证券交易所代码:BEAR)

Hill Street Beverage Company Inc. is a progressive non-alcoholic beverage and cannabis solutions company. We are pioneering the space where craft consumer products meet bioscience by combining our deep CPG expertise and our rights to use Lexaria Bioscience Corp.'s ground-breaking DehydraTECH™ patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

希尔街饮料公司(Hill Street Beverage Company Inc.)是一家进步的非酒精饮料和大麻解决方案公司。通过将我们深厚的CPG专业知识和我们的使用权相结合,我们正在开创工艺消费品与生物科学相结合的领域。利卡里亚生物科学公司(Lexaria Bioscience Corp.)开创性的脱氢技术™大麻成分的产品开发、许可和B2B销售的专利组合。

Hill Street Beverages brands include Vin(Zero) alcohol-free wines and Hill Street Craft Brewed Lager, and have won numerous medals and accolades around the world. Hill Avenue Cannabis Brands include (V)ia Regal Pink and White Grape Sparklers.

山街饮料品牌包括Vin(零)不含酒精葡萄酒和希尔街手工酿造的啤酒,并在世界各地赢得了无数的奖牌和赞誉。希尔大道大麻品牌包括(V)富豪国际酒店(Ia Regal)粉色和白色葡萄闪闪发光。

For more information on our business activities or to check out Hill Street's award-winning alcohol-free line-up and order product to be delivered straight to your home go to .

欲了解更多有关我们业务活动的信息或查看希尔街的屡获殊荣的不含酒精产品阵容和订单产品可直接送到您的家中。

For more information:

了解更多信息:

Craig Binkley, Chief Executive Officer
craig@hillstreetbevco.com.

克雷格·宾克利(Craig Binkley),首席执行官
地址:Craig@hillstreetbevco.com

FORWARD-LOOKING STATEMENTS

前瞻性陈述

Statements in this press release may contain forward-looking information. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "would", "anticipate", "expects", and similar expressions. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances, such as future availability of capital on favourable terms, may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities law.

本新闻稿中的陈述可能包含前瞻性信息。本新闻稿中任何非历史事实的陈述均可被视为前瞻性陈述。前瞻性陈述通常由诸如“可能”、“应该”、“将”、“预期”、“预期”以及类似的表达方式来识别。提醒读者,在准备任何前瞻性信息时使用的假设可能被证明是不正确的。由于许多已知和未知的风险、不确定性和其他因素,其中许多不是公司所能控制的,诸如未来以有利条件获得资本等事件或情况可能导致实际结果与预测的结果大不相同。提醒读者不要过度依赖任何前瞻性信息。这些信息虽然在准备时被管理层认为是合理的,但可能被证明是不正确的,实际结果可能与预期的大不相同。本新闻稿中包含的前瞻性陈述明确受本警告性声明的限制。本新闻稿中包含的前瞻性陈述是截至本新闻稿发布之日作出的。除非证券法要求,否则公司不承担公开更新或修改任何包含的前瞻性陈述的义务,无论是由于新信息、未来事件还是其他原因。

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所创业板交易所及其监管服务提供商(该术语在多伦多证券交易所创业板政策中定义)均不对本新闻稿的充分性或准确性承担责任。

Not for dissemination in the United States.

不能在美国传播。

To view the source version of this press release, please visit

要查看本新闻稿的源版本,请访问

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发